Vertex Ventures China

Founded 2008

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 92
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 79
Rounds per year 7.08
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 8
Key employees 5
Stages of investment
Early Stage Venture

Areas of investment

  • Internet
  • E-Commerce
  • Software
  • Manufacturing
  • Information Technology
Summary

Vertex Ventures China is the famous VC, which was founded in 2008. The company was established in Asia in China. The main department of described VC is located in the Beijing.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Vertex Ventures China, startups are often financed by CDH Investments, Bertelsmann Asia Investments, SAIF Partners. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures, Sinovation Ventures, Matrix Partners China. In the next rounds fund is usually obtained by Sequoia Capital China, Qiming Venture Partners, Matrix Partners China.

The fund is constantly included in 7-12 deals per year. Speaking about the real fund results, this VC is 19 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Vertex Ventures China the average startup value is 100-500 millions dollars. The higher amount of exits for fund were in 2018. This Vertex Ventures China works on 21 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2014. Despite it in 2019 the fund had an activity.

We can highlight the next thriving fund investment areas, such as Internet, Manufacturing. For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Horizon Robotics, Mobike, 91 Boyuan Wireless. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

Besides them, we counted 5 critical employees of this fund in our database.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Semidrive

Semiconductor
$154M26 Jul 2021 Xuanwu District, Jiangsu, China

Nutrition
Pet
$30M04 Dec 2020 China, Shanghai

Cardinal Operations

Analytics
Big Data
Information Services
Information Technology
$15M12 Aug 2020 Dongcheng District, Beijing, China

SmartX

Cloud Infrastructure
Data Storage
Enterprise Software
Flash Storage
Infrastructure
Software
Virtualization
25 Jul 2020 China, Beijing

26 May 2020 Futian District, Guangdong Province

Shanshu Keji

E-Commerce
Supply Chain Management
$15M18 May 2020 Chengdu, Sichuan, China

Xiaoduo

Artificial Intelligence
Customer Service
Robotics
$30M13 Apr 2020 Qingyang District, Sichuan, China

Internet of Things
Semiconductor
13 Mar 2020 Shushan District, Anhui

Wangbaobao

E-Commerce
26 Dec 2019 Shangcheng District, Zhejiang, China
News
Regor Therapeutics Announces Completion of $90 Million Series B Financing

– Regor Therapeutics announced the successful completion of $90m Series B financing.
– The round was led by Lilly Asia Ventures and included participation from Loyal Valley Capital, Lanting Capital, TF Capital and Vertex Ventures China.
– Regor Therapeutics was established with initial series A strategic investment from Qilu Pharmaceutical Group, a well-known Chinese pharmaceutical company.
– Regor Therapeutics is a clinical stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) Platform, seamlessly integrating structural biology, computational chemistry, therapeutic biology, medicinal chemistry, and clinical development.
– Regor has assembled a world-class scientific team and demonstrated high efficiency in producing best- and first-in-class molecules.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Vertex Ventures China?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: